Published in J Exp Med on March 01, 1996
Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol (2009) 3.13
Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol (2011) 2.81
Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med (2000) 2.51
Preselection thymocytes are more sensitive to T cell receptor stimulation than mature T cells. J Exp Med (1998) 1.99
How many thymocytes audition for selection? J Exp Med (1997) 1.90
How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat Immunol (2012) 1.80
Negative selection in the thymus includes semimature T cells. J Exp Med (1997) 1.77
Sensory adaptation in naive peripheral CD4 T cells. J Exp Med (2001) 1.65
Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J Exp Med (2002) 1.48
Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J Exp Med (2000) 1.46
CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc Natl Acad Sci U S A (2006) 1.46
Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc Natl Acad Sci U S A (1996) 1.44
A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex. J Exp Med (1999) 1.36
Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands. J Exp Med (2001) 1.33
Functional management of an antiviral cytotoxic T-cell response. J Virol (1997) 1.30
Signaling in thymic selection. Curr Opin Immunol (2011) 1.29
CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J Exp Med (2002) 1.22
Vav regulates peptide-specific apoptosis in thymocytes. J Exp Med (1998) 1.12
Glucocorticoids attenuate T cell receptor signaling. J Exp Med (2001) 1.10
Potent T cell agonism mediated by a very rapid TCR/pMHC interaction. Eur J Immunol (2007) 1.06
T cell development and T cell responses in mice with mutations affecting tyrosines 292 or 315 of the ZAP-70 protein tyrosine kinase. J Exp Med (2001) 1.04
A T cell receptor-specific blockade of positive selection. J Exp Med (1999) 0.93
Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands. Proc Natl Acad Sci U S A (1998) 0.93
Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes. Proc Natl Acad Sci U S A (1998) 0.93
Interactions with multiple peptide ligands determine the fate of developing thymocytes. Proc Natl Acad Sci U S A (1998) 0.89
CD3 ligation on immature thymocytes generates antagonist-like signals appropriate for CD8 lineage commitment, independently of T cell receptor specificity. J Exp Med (1998) 0.88
T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity. Int Rev Immunol (2006) 0.88
The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. Proc Natl Acad Sci U S A (1998) 0.84
Cellular and molecular requirements for the selection of in vitro-generated CD8 T cells reveal a role for Notch. J Immunol (2013) 0.84
Positive selection of CD4(+) T cells is induced in vivo by agonist and inhibited by antagonist peptides. J Exp Med (2001) 0.83
Signal transduction via the T cell antigen receptor in naïve and effector/memory T cells. Int J Biochem Cell Biol (2012) 0.81
An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II-restricted T cells in the absence of CD4. J Exp Med (2005) 0.81
Subcellular distribution of Lck during CD4 T-cell maturation in the thymic medulla regulates the T-cell activation threshold. Proc Natl Acad Sci U S A (2012) 0.81
Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide. Proc Natl Acad Sci U S A (1998) 0.79
Recognition of the major histocompatibility complex restriction element modulates CD8(+) T cell specificity and compensates for loss of T cell receptor contacts with the specific peptide. J Exp Med (1999) 0.78
Review article: thymus organ cultures and T-cell receptor repertoire development. Immunology (2000) 0.77
T cell receptor antagonism in vivo, at last. Proc Natl Acad Sci U S A (1998) 0.75
The molecular jury: deciding whether immature thymocytes should live or die. J Exp Med (1996) 0.75
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (1988) 11.55
Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature (1985) 9.62
Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science (1990) 8.17
Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature (1989) 7.52
Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature (1989) 7.11
Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature (1990) 5.41
Evidence for a differential avidity model of T cell selection in the thymus. Cell (1994) 5.24
Peptides naturally presented by MHC class I molecules. Annu Rev Immunol (1993) 4.66
Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature (1988) 4.63
Peripheral selection of the T cell repertoire. Science (1991) 4.56
The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype. J Exp Med (1984) 4.29
T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature (1988) 4.04
Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature (1988) 4.02
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (1993) 3.83
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell (1994) 3.71
Positive selection of thymocytes. Annu Rev Immunol (1995) 3.68
Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (1991) 3.58
Negative selection of lymphocytes. Cell (1994) 3.47
Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (1995) 3.40
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell (1992) 3.24
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today (1993) 2.91
Positive selection of lymphocytes. Cell (1994) 2.86
Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science (1994) 2.86
Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature (1991) 2.66
Expression and functional significance of the J11d marker on mouse thymocytes. J Immunol (1987) 2.56
T cell selection in the thymus. Immunol Rev (1988) 2.53
A nondeletional mechanism of thymic self tolerance. Science (1989) 2.41
The thymic microenvironment. Immunol Today (1993) 2.36
Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db. Proc Natl Acad Sci U S A (1986) 2.26
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell (1989) 2.20
Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus. Cell (1993) 1.96
The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection. Cell (1994) 1.90
Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc Natl Acad Sci U S A (1992) 1.83
Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity (1995) 1.80
Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J Exp Med (1993) 1.77
A role for clonal inactivation in T cell tolerance to Mls-1a. Nature (1990) 1.75
Specificity and flexibility in thymic selection. Nature (1994) 1.72
In vivo and in vitro clonal deletion of double-positive thymocytes. J Exp Med (1992) 1.66
The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell (1990) 1.58
A differential-avidity model for T-cell selection. Immunol Today (1994) 1.53
Thymic epithelium tolerizes for histocompatibility antigens. Science (1990) 1.53
Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells. Immunity (1995) 1.47
Ligands for the T-cell receptor: hard times for avidity models. Immunol Today (1995) 1.46
Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol (1992) 1.32
Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J Exp Med (1994) 1.31
Tolerogenicity of thymic epithelium. Eur J Immunol (1990) 1.18
Recognition of multiple peptide cores by a single T cell receptor. J Exp Med (1995) 1.17
Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists. Proc Natl Acad Sci U S A (1994) 1.15
Thymus epithelium induces tissue-specific tolerance. J Exp Med (1993) 1.13
Positive selection of TcR alpha beta thymocytes: is cortical thymic epithelium an obligatory participant in the presentation of major histocompatibility complex protein? Immunol Rev (1993) 1.09
T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues. J Immunol (1993) 1.08
Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny. J Exp Med (1992) 1.06
Immunological function of a defined T-cell population tolerized to low-affinity self antigens. Nature (1995) 1.02
Ligand thresholds at different stages of T cell development. Int Immunol (1990) 1.01
Thymic selection: two pathways to life and two to death. Immunity (1994) 1.01
Cellular tolerance as a dynamic state of the adaptable lymphocyte. Immunol Rev (1993) 0.99
Increase in positive selection of CD8+ T cells in TAP1-mutant mice by human beta 2-microglobulin transgene. J Exp Med (1995) 0.93
Are MHC-bound peptides a nuisance for positive selection? Immunity (1994) 0.91
Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling. J Immunol (1992) 0.85
A unified model for T cell antigen recognition and thymic selection of the T cell repertoire. J Theor Biol (1991) 0.81
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell (1993) 9.84
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
Group selection for a polygenic behavioral trait: estimating the degree of population subdivision. Proc Natl Acad Sci U S A (1984) 7.04
Differential T cell costimulatory requirements in CD28-deficient mice. Science (1993) 6.93
Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3. DNA Res (1998) 6.79
Visible-light photocatalysis in nitrogen-doped titanium oxides. Science (2001) 6.68
Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature (1990) 6.59
Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature (1991) 5.98
Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science (2000) 5.84
Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science (1995) 5.27
T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity (2001) 4.62
Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell (1993) 4.46
Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science (1997) 4.23
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature (2000) 4.08
CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell (1991) 4.05
ICOS is essential for effective T-helper-cell responses. Nature (2001) 4.01
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell (2001) 3.80
The influence of antigen organization on B cell responsiveness. Science (1993) 3.32
On immunological memory. Annu Rev Immunol (1996) 3.21
Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6. Proc Natl Acad Sci U S A (1986) 3.15
Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell (1993) 3.07
Complete genome sequence of an aerobic thermoacidophilic crenarchaeon, Sulfolobus tokodaii strain7. DNA Res (2001) 2.99
Primary structural: analysis of the transplantation antigens of the murine H-2 major histocompatibility complex. Annu Rev Biochem (1981) 2.93
Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science (1994) 2.86
Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer. Nature (1985) 2.84
Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat Immunol (2001) 2.83
CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood (1997) 2.71
Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med (2000) 2.61
On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci U S A (1996) 2.55
Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med (2000) 2.51
Spontaneous H-2 mutants provide evidence that a copy mechanism analogous to gene conversion generates polymorphism in the major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 2.51
Biochemistry of the gene products from murine MHC mutants. Annu Rev Genet (1980) 2.49
Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J Exp Med (1997) 2.47
Primary structure of a murine transplantation antigen. Nature (1981) 2.42
Structural and serological properties of murine Ia alloantigens. Transplant Rev (1976) 2.35
Solubilization and partial purification of mouse histocompatibility antigens from a membranous lipoprotein fraction. Proc Natl Acad Sci U S A (1966) 2.33
Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications. Annu Rev Immunol (1986) 2.29
Isolation of H-2 alloantigens solubilized by the detergent NP-40. J Immunol (1971) 2.26
Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity (1997) 2.25
Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J Exp Med (1991) 2.24
Mechanism of Methane Transport from the Rhizosphere to the Atmosphere through Rice Plants. Plant Physiol (1990) 2.24
Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc Natl Acad Sci U S A (1997) 2.23
Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med (1992) 2.22
Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature (2001) 2.21
Selection of the T cell repertoire. Annu Rev Immunol (1999) 2.21
T cell-specific gamma genes in C57BL/10 mice. Sequence and expression of new constant and variable region genes. J Exp Med (1986) 2.20
Membrane molecules determined by the H-2 associated immune response region: isolation and some properties. Proc Natl Acad Sci U S A (1974) 2.17
Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc Natl Acad Sci U S A (1992) 2.16
LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J Exp Med (1996) 2.14
Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity (1996) 2.08
Group selection for a polygenic behavioral trait: a differential proliferation model. Proc Natl Acad Sci U S A (1982) 2.08
Murine histocompatibility-2 (H-2) alloantigens. Purification and some chemical properties of soluble products from H-2b and H-2d genotypes released by papain digestion of membrane fractions. Biochemistry (1969) 2.06
The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity (1998) 2.06
Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science (1995) 2.01
Illegitimate recombination mediated in vitro by DNA gyrase of Escherichia coli: structure of recombinant DNA molecules. Proc Natl Acad Sci U S A (1982) 1.97
Rapid diagnosis of adenoviral conjunctivitis by PCR and restriction fragment length polymorphism analysis. J Clin Microbiol (1996) 1.94
Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences. Proc Natl Acad Sci U S A (1983) 1.92
Biochemical properties and immunochemical-genetic relationships of mouse H-2 alloantigens. Biochim Biophys Acta (1974) 1.91
The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection. Cell (1994) 1.90
The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med (1998) 1.88
Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science (2001) 1.87
A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat Immunol (2001) 1.85
Intermolecular relations of the photosystem II complex in spinach chloroplasts as detected by immunochemical assay. J Biochem (1986) 1.85
Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development. J Immunol (1997) 1.84
Simulation model of an eyeball based on finite element analysis on a supercomputer. Br J Ophthalmol (1999) 1.83
Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc Natl Acad Sci U S A (1998) 1.82
Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3 (supplement). DNA Res (1998) 1.81
The genome-linked protein of picornaviruses. VII. Genetic mapping of poliovirus VPg by protein and RNA sequence studies. Cell (1980) 1.80
Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell (1988) 1.77
Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol (2000) 1.77
Letter: HL-A5 and Behçet's disease. Lancet (1973) 1.76
Atomic structure of an alphabeta T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody. EMBO J (1998) 1.74
Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A (2000) 1.73
Notable diversity in peptide composition of murine H-2K and H-2D alloantigens. Biochemistry (1974) 1.70
An optical spectrum of the afterglow of a gamma-ray burst at a redshift of z = 6.295. Nature (2006) 1.70
Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity (2000) 1.69
The distribution of alloantigenic specificities of native H-2 products. J Immunol (1972) 1.69
H-2 histocompatibility alloantigens. Some biochemical properties of the molecules solubilized by NP-40 detergent. Biochemistry (1973) 1.68
A test of significance for geographic clusters of disease. Int J Epidemiol (1979) 1.68
Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol (1999) 1.66
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clin Exp Allergy (2009) 1.66
Specific histocompatibility antigens associated with Behçet's disease. Am J Ophthalmol (1975) 1.63
TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity (1999) 1.56
Regeneration of transplantation antigens on mouse cells. Transplant Proc (1971) 1.56
Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J (1978) 1.55
Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med (2000) 1.50
Interaction between Kb and Q4 gene sequences generates the Kbm6 mutation. Mol Cell Biol (1986) 1.50
Suppression of immunoglobulin synthesis by cellular hybridization. Nat New Biol (1971) 1.50
Structural differences between parent and mutant H-2K glycoproteins from two H-2K gene mutants: b6.c-h-2ba (Hzl) and B6-H-2bd (M505). J Immunol (1977) 1.48
Identification of the cloned gene for the murine transplantation antigen H-2Kb by hybridization with synthetic oligonucleotides. Mol Cell Biol (1983) 1.48